137 related articles for article (PubMed ID: 18312218)
21. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial.
Izmirlian G
Ann N Y Acad Sci; 2004 May; 1020():154-74. PubMed ID: 15208191
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
23. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
24. Finding diagnostic biomarkers in proteomic spectra.
Pratapa PN; Patz EF; Hartemink AJ
Pac Symp Biocomput; 2006; ():279-90. PubMed ID: 17094246
[TBL] [Abstract][Full Text] [Related]
25. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
[TBL] [Abstract][Full Text] [Related]
26. Organizing a competition on clinical mass spectrometry based proteomic diagnosis.
Mertens B
Stat Appl Genet Mol Biol; 2008; 7(2):Article3. PubMed ID: 18312217
[TBL] [Abstract][Full Text] [Related]
27. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics.
Hendriks MM; Smit S; Akkermans WL; Reijmers TH; Eilers PH; Hoefsloot HC; Rubingh CM; de Koster CG; Aerts JM; Smilde AK
Proteomics; 2007 Oct; 7(20):3672-80. PubMed ID: 17880000
[TBL] [Abstract][Full Text] [Related]
28. Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging.
Meding S; Nitsche U; Balluff B; Elsner M; Rauser S; Schöne C; Nipp M; Maak M; Feith M; Ebert MP; Friess H; Langer R; Höfler H; Zitzelsberger H; Rosenberg R; Walch A
J Proteome Res; 2012 Mar; 11(3):1996-2003. PubMed ID: 22224404
[TBL] [Abstract][Full Text] [Related]
29. Proteomic identification and profiling of canine lymphoma patients.
Ratcliffe L; Mian S; Slater K; King H; Napolitano M; Aucoin D; Mobasheri A
Vet Comp Oncol; 2009 Jun; 7(2):92-105. PubMed ID: 19453363
[TBL] [Abstract][Full Text] [Related]
30. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
31. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
[TBL] [Abstract][Full Text] [Related]
32. High-accuracy peak picking of proteomics data using wavelet techniques.
Lange E; Gröpl C; Reinert K; Kohlbacher O; Hildebrandt A
Pac Symp Biocomput; 2006; ():243-54. PubMed ID: 17094243
[TBL] [Abstract][Full Text] [Related]
33. A strategy for the prior processing of high-resolution mass spectral data obtained from high-dimensional combined fractional diagonal chromatography.
Valkenborg D; Thomas G; Krols L; Kas K; Burzykowski T
J Mass Spectrom; 2009 Apr; 44(4):516-29. PubMed ID: 19065607
[TBL] [Abstract][Full Text] [Related]
34. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
[TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
[TBL] [Abstract][Full Text] [Related]
36. Cancer informatics by prototype networks in mass spectrometry.
Schleif FM; Villmann T; Kostrzewa M; Hammer B; Gammerman A
Artif Intell Med; 2009; 45(2-3):215-28. PubMed ID: 18778925
[TBL] [Abstract][Full Text] [Related]
37. Serum protein profiles in myasthenia gravis.
Cheng C; Wu G; Yeung SC; Li R; Bella AE; Pang J; Zhong FT; Luo H; Jin Y; Pan J
Ann Thorac Surg; 2009 Oct; 88(4):1118-23. PubMed ID: 19766792
[TBL] [Abstract][Full Text] [Related]
38. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
39. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
40. Biomarker selection and sample prediction for multi-category disease on MALDI-TOF data.
Oh JH; Kim YB; Gurnani P; Rosenblatt KP; Gao JX
Bioinformatics; 2008 Aug; 24(16):1812-8. PubMed ID: 18562269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
